We found a significant decrease in Aβ42, and a significant increase in t-tau, p-tau, t-tau/Aβ42 and p-tau/Aβ42, in the AD group compared with both the non-AD and control groups (Ps < 0.01, Table 1). Here, MAPT is linked to Alzheimer disease.